283 related articles for article (PubMed ID: 16356813)
21. Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases.
Ascenti G; Visalli C; Genitori A; Certo A; Pitrone A; Mazziotti S
Clin Imaging; 2004; 28(5):349-52. PubMed ID: 15471667
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
23. [Magnetic resonance tomography for the detection and staging of kidney cancer].
Otvetchikov IN; Akhadov TA
Urol Nefrol (Mosk); 1996; (4):9-14. PubMed ID: 8928354
[TBL] [Abstract][Full Text] [Related]
24. [Chromophobe cell renal carcinoma: a case report].
Nakazawa M; Yamaguchi K; Ishizuka O; Nishizawa O
Hinyokika Kiyo; 1999 Mar; 45(3):179-82. PubMed ID: 10331170
[TBL] [Abstract][Full Text] [Related]
25. [The pathological/MR tomographic correlation and differential diagnosis of malignant kidney tumors].
Kreft B; Flacke S; Conrad R; Pauleit D; Bachmann R; Wardelmann E; Albers P; Schild H
Rofo; 1999 Aug; 171(2):106-12. PubMed ID: 10506883
[TBL] [Abstract][Full Text] [Related]
26. Imaging techniques for the patient with renal cell carcinoma.
Gardner TA; Tirkes T; Mellon M; Koch MO
Semin Nephrol; 2011 May; 31(3):245-53. PubMed ID: 21784273
[TBL] [Abstract][Full Text] [Related]
27. The imaging evaluation of renal cell carcinoma: diagnosis and staging.
McClennan BL; Deyoe LA
Radiol Clin North Am; 1994 Jan; 32(1):55-69. PubMed ID: 8284361
[TBL] [Abstract][Full Text] [Related]
28. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
29. Imaging in renal cell carcinoma.
Krajewski KM; Giardino AA; Zukotynski K; Van den Abbeele AD; Pedrosa I
Hematol Oncol Clin North Am; 2011 Aug; 25(4):687-715. PubMed ID: 21763963
[TBL] [Abstract][Full Text] [Related]
30. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
[TBL] [Abstract][Full Text] [Related]
31. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
32. Current role and future perspective of MRI for diagnosis and characterization of renal cell carcinoma.
Schoth F; Persigehl T; Palmowski M
Panminerva Med; 2010 Dec; 52(4):307-18. PubMed ID: 21183891
[TBL] [Abstract][Full Text] [Related]
33. Computed tomography and magnetic resonance imaging of adult renal cell carcinoma associated with Xp11.2 translocation.
Dang TT; Ziv E; Weinstein S; Meng MV; Wang Z; Coakley FV
J Comput Assist Tomogr; 2012; 36(6):669-74. PubMed ID: 23192203
[TBL] [Abstract][Full Text] [Related]
34. Wilms' tumor and other pediatric renal masses.
Siegel MJ; Chung EM
Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):479-97, vi. PubMed ID: 18585600
[TBL] [Abstract][Full Text] [Related]
35. Three-dimensional fast spoiled gradient-echo dual echo (3D-FSPGR-DE) with water reconstruction: preliminary experience with a novel pulse sequence for gadolinium-enhanced abdominal MR imaging.
Low RN; Panchal N; Vu AT; Knowles A; Estkowski L; Slavens Z; Ma J
J Magn Reson Imaging; 2008 Oct; 28(4):946-56. PubMed ID: 18821620
[TBL] [Abstract][Full Text] [Related]
36. Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies.
Kondo T; Nakazawa H; Sakai F; Kuwata T; Onitsuka S; Hashimoto Y; Toma H
Int J Urol; 2004 Oct; 11(10):817-24. PubMed ID: 15479284
[TBL] [Abstract][Full Text] [Related]
37. Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging.
Tsuda K; Kinouchi T; Tanikawa G; Yasuhara Y; Yanagawa M; Kakimoto K; Ono Y; Meguro N; Maeda O; Arisawa J; Usami M
Int J Urol; 2005 Sep; 12(9):795-800. PubMed ID: 16201974
[TBL] [Abstract][Full Text] [Related]
38. [Significance of ultrasonography in detecting renal cell carcinoma].
Esa A; Takada M; Tsujihashi H; Park YC; Kaneko S; Akiyama T; Kurita T
Hinyokika Kiyo; 1989 Jun; 35(6):963-7. PubMed ID: 2678979
[TBL] [Abstract][Full Text] [Related]
39. The diagnosis, staging, and follow-up of carcinomas of the kidney, bladder, and prostate: the role of cross-sectional imaging.
Singer J; McClennan BL
Semin Ultrasound CT MR; 1989 Dec; 10(6):481-97. PubMed ID: 2697358
[No Abstract] [Full Text] [Related]
40. State-of-the-art magnetic resonance imaging of pancreatic cancer.
Schima W; Ba-Ssalamah A; Goetzinger P; Scharitzer M; Koelblinger C
Top Magn Reson Imaging; 2007 Dec; 18(6):421-9. PubMed ID: 18303400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
